Quantbot Technologies LP Cuts Holdings in National Health Investors, Inc. $NHI

Quantbot Technologies LP trimmed its position in National Health Investors, Inc. (NYSE:NHI) by 43.1% during the 3rd quarter, HoldingsChannel reports. The firm owned 14,700 shares of the real estate investment trust’s stock after selling 11,151 shares during the quarter. Quantbot Technologies LP’s holdings in National Health Investors were worth $1,169,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in NHI. EverSource Wealth Advisors LLC boosted its stake in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after buying an additional 288 shares during the last quarter. Assetmark Inc. increased its stake in National Health Investors by 19.0% in the 2nd quarter. Assetmark Inc. now owns 925 shares of the real estate investment trust’s stock worth $65,000 after acquiring an additional 148 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in shares of National Health Investors by 24.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,128 shares of the real estate investment trust’s stock worth $90,000 after acquiring an additional 225 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of National Health Investors by 212.4% during the 3rd quarter. Smartleaf Asset Management LLC now owns 1,206 shares of the real estate investment trust’s stock worth $95,000 after acquiring an additional 820 shares in the last quarter. Finally, NewEdge Advisors LLC boosted its position in shares of National Health Investors by 28.7% during the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after acquiring an additional 345 shares during the last quarter. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Price Performance

Shares of National Health Investors stock opened at $84.60 on Friday. The stock has a market cap of $4.09 billion, a price-to-earnings ratio of 28.01, a price-to-earnings-growth ratio of 4.51 and a beta of 0.65. The company has a debt-to-equity ratio of 0.76, a quick ratio of 6.90 and a current ratio of 6.90. The stock has a 50 day moving average price of $82.58 and a 200-day moving average price of $79.08. National Health Investors, Inc. has a one year low of $66.41 and a one year high of $91.38.

National Health Investors (NYSE:NHI) last released its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.01). The company had revenue of $105.82 million for the quarter, compared to analysts’ expectations of $95.12 million. National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.24 EPS. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. Equities analysts expect that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Tuesday, March 31st will be paid a $0.92 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.68 annualized dividend and a dividend yield of 4.3%. National Health Investors’s dividend payout ratio is currently 121.85%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on NHI shares. Wells Fargo & Company raised their target price on shares of National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, November 25th. Cantor Fitzgerald set a $85.00 price target on shares of National Health Investors in a research note on Monday, January 5th. Truist Financial lifted their price objective on shares of National Health Investors from $81.00 to $83.00 and gave the stock a “buy” rating in a research note on Monday, December 15th. KeyCorp boosted their target price on shares of National Health Investors from $80.00 to $88.00 and gave the stock an “overweight” rating in a report on Thursday, December 4th. Finally, National Bank Financial set a $85.00 target price on shares of National Health Investors in a research report on Tuesday, January 20th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, National Health Investors presently has an average rating of “Moderate Buy” and a consensus price target of $85.57.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.